The Coefficient of Variation of Red Blood Cell Distribution Width Combined with Cancer Antigen 125 Predicts Postoperative Overall Survival in Endometrial Cancer
Wenhui Zhong,Chunyu Zhou,Lufei Chen,Zhenna Wang,Hongxing Lin,Kunhai Wu,Sujiao Zhang
DOI: https://doi.org/10.2147/IJGM.S323136
IF: 2.145
2021-09-21
International Journal of General Medicine
Abstract:Wenhui Zhong, 1, &ast Chunyu Zhou, 2, &ast Lufei Chen, 1 Zhenna Wang, 3 Hongxing Lin, 1 Kunhai Wu, 1 Sujiao Zhang 4 1 Clinical Laboratory, Fujian Maternity and Child Health Hospital, Affiliated Hospital of Fujian Medical University, Fuzhou, People's Republic of China; 2 Nursing Department, Fujian Medical University Union Hospital, Fuzhou, People's Republic of China; 3 Department of Gynecology, Fujian Maternity and Child Health Hospital, Affiliated Hospital of Fujian Medical University, Fuzhou, People's Republic of China; 4 Department of Pathology, Fujian Maternity and Child Health Hospital, Affiliated Hospital of Fujian Medical University, Fuzhou, People's Republic of China &astThese authors contributed equally to this work Correspondence: Wenhui Zhong Clinical Laboratory, Fujian Maternity and Child Health Hospital, Affiliated Hospital of Fujian Medical University, No. 18 Daoshan Road, Fuzhou, 350001, Fujian, People's Republic of China Email Purpose: This study assessed the prognostic value of red blood cell distribution width (RDW) and cancer antigen 125 (CA125) in predicting the prognosis of endometrial cancer (EC) patients. Patients and Methods: In this study, we included 525 patients with EC between January 2013 and January 2019. Demographic and clinical indicators were collected, and the receiver operating characteristics curve (ROC) and cutoff values were calculated between the early and advanced stages of EC. Independent risk factors associated with EC prognosis were assessed using Cox regression analyses and the Kaplan–Meier method. Results: Compared to women in the early stage of EC, women with advanced stage had significantly elevated RDW coefficient of variation (RDW-CV) and CA125 levels and lower mean corpuscular volume (MCV) and mean corpuscular hemoglobin (MCH) (both P < 0.05). Consequently, RDW-CV and CA125 were found to be independent risk factors for EC by using ROC curve and multivariate logistic regression analysis. The survival analysis curve was used to assess the diagnostic value of RDW-CV, CA125, and their combination in the prognosis of EC. The results showed that patients with high expression of RDW-CV and CA125 had worse overall survival than those with low expression. Moreover, multivariate Cox regression analysis indicated that RDW-CV+CA125=2 was an independent prognostic factor. Conclusion: These findings suggest that CA125 combined with RDW-CV has a good prognostic value for EC. Thus, the RDW-CV+CA125 score is a promising prognostic marker for the clinical decision-making process regarding EC outcomes. Keywords: CA125, RDW-CV, endometrial cancer, prognosis Endometrial cancer (EC) is the most common gynecological malignancy in developed countries, and its incidence is increasing each year. 1 Patients with early stage EC have a good prognosis, with a 5-year survival rate of 74–91%, while patients diagnosed with stage III or IV EC have a 5-year survival rate of 57–66% and 20–26%, respectively. 2 According to statistics, EC has a long onset period and high insidiousness, meaning its symptoms are not meaningful at the early stages of the disease. 3 Moreover, studies have shown that 10–20% of patients with early EC and 50–70% of patients with advanced EC have a poor prognosis. 4 Therefore, identification of reliable and feasible biomarkers is needed for the detection of EC patients with poor prognosis, development of individualized treatments, and implementation of follow-up protocols. At present, cancer antigen 125 (CA125), is associated with the prognosis of EC. 5 However, when patients with non-EC suffer from endometriosis, 6 hepatitis, 7 or when the body is in the inflammatory response period, the level of serum CA125 will also increase to varying degrees. Therefore, the specificity of CA125 as a tumor marker for EC is not high, and it is not recommended to use CA125 alone as a prognostic indicator of EC. Red blood cell (RBC) distribution width (RDW) is a parameter reflecting the variation degree of red blood cell volume, which is often used in the clinical diagnosis of anemia types such as iron deficiency anemia and thalassemia. 8 He et al 9 confirmed that RDW was positively correlated with erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP), suggesting that changes in RDW may be related to the inflammatory state of the body. Clinical data have also shown that chronic inflammation is closely related to the progression of cancer. 10 Recent studies have reported the expression of RDW in various common tumors, such as breast -Abstract Truncated-
medicine, general & internal